Molecular Genetic Characterization of Individual Cancer Cells Isolated via Single-Cell Printing
Open Access
- 22 September 2016
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 11 (9), e0163455
- https://doi.org/10.1371/journal.pone.0163455
Abstract
Intratumoral genetic heterogeneity may impact disease outcome. Gold standard for dissecting clonal heterogeneity are single-cell analyses. Here, we present an efficient workflow based on an advanced Single-Cell Printer (SCP) device for the study of gene variants in single cancer cells. To allow for precise cell deposition into microwells the SCP was equipped with an automatic dispenser offset compensation, and the 384-microwell plates were electrostatically neutralized. The ejection efficiency was 99.7% for fluorescent beads (n = 2304) and 98.7% for human cells (U-2 OS or Kasumi-1 cancer cell line, acute myeloid leukemia [AML] patient; n = 150). Per fluorescence microscopy, 98.8% of beads were correctly delivered into the wells. A subset of single cells (n = 81) was subjected to whole genome amplification (WGA), which was successful in all cells. On empty droplets, a PCR on LINE1 retrotransposons yielded no product after WGA, verifying the absence of free-floating DNA in SCP-generated droplets. Representative gene variants identified in bulk specimens were sequenced in single-cell WGA DNA. In U-2 OS, 22 of 25 cells yielded results for both an SLC34A2 and TET2 mutation site, including cells harboring the SLC34A2 but not the TET2 mutation. In one cell, the TET2 mutation analysis was inconclusive due to allelic dropout, as assessed via polymorphisms located close to the mutation. Of Kasumi-1, 23 of 33 cells with data on both the KIT and TP53 mutation site harbored both mutations. In the AML patient, 21 of 23 cells were informative for a TP53 polymorphism; the identified alleles matched the loss of chromosome arm 17p. The advanced SCP allows efficient, precise and gentle isolation of individual cells for subsequent WGA and routine PCR/sequencing-based analyses of gene variants. This makes single-cell information readily accessible to a wide range of applications and can provide insights into clonal heterogeneity that were indeterminable solely by analyses of bulk specimens.Keywords
Funding Information
- University of Freiburg (BEC1058/15)
- Deutsche Krebshilfe (DKH 111210)
- European Hematology Association/American Society of Hematology (TRTH 2013)
- Deutsche Krebshilfe (DKH 110461)
- Seventh Framework Programme (257073)
- European Hematology Association
This publication has 29 references indexed in Scilit:
- Tumour heterogeneity in the clinicNature, 2013
- Spontaneous electrical charging of droplets by conventional pipettingScientific Reports, 2013
- Genotype Misclassification in Genetic Association Studies of the rs1042522 TP53 (Arg72Pro) Polymorphism: A Systematic Review of Studies of Breast, Lung, Colorectal, Ovarian, and Endometrial CancerAmerican Journal of Epidemiology, 2013
- Mutations and polymorphisms in TP53 gene--an overview on the role in colorectal cancerMutagenesis, 2012
- Tumour evolution inferred by single-cell sequencingNature, 2011
- Acquired mutations in TET2 are common in myelodysplastic syndromesNature Genetics, 2009
- Two cell lines of t(8;21) acute myeloid leukemia with activating KIT exon 17 mutation: models for the ‘second hit’ hypothesisLeukemia, 2008
- The codon 72 polymorphic variants of p53 have markedly different apoptotic potentialNature Genetics, 2003
- Amplification of a novel c-Kit activating mutation Asn822-Lys in the Kasumi-1 cell line: a t(8;21)-Kit mutant model for acute myeloid leukemiaThe Hematology Journal, 2002
- Comprehensive human genome amplification using multiple displacement amplificationProceedings of the National Academy of Sciences of the United States of America, 2002